These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18240904)

  • 1. Ethnic differences in the VKORC1 gene polymorphism and an association with warfarin dosage requirements in cardiovascular surgery patients.
    Nakai K; Tsuboi J; Okabayashi H; Fukuhiro Y; Oka T; Habano W; Fukushima N; Nakai K; Obara W; Fujioka T; Suwabe A; Gurwitz D
    Pharmacogenomics; 2007 Jul; 8(7):713-9. PubMed ID: 18240904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of combined CYP2C9 and VKORC1 genotypes in Japanese patients requiring warfarin.
    Miyagata Y; Nakai K; Sugiyama Y
    Int Heart J; 2011; 52(1):44-9. PubMed ID: 21321468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.
    Ekladious SM; Issac MS; El-Atty Sharaf SA; Abou-Youssef HS
    Mol Diagn Ther; 2013 Dec; 17(6):381-90. PubMed ID: 23839801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.
    Scott SA; Edelmann L; Kornreich R; Desnick RJ
    Am J Hum Genet; 2008 Feb; 82(2):495-500. PubMed ID: 18252229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of CYP2C9 and VKORC1 risk alleles for warfarin sensitivity and resistance in the Israeli population.
    Efrati E; Elkin H; Sprecher E; Krivoy N
    Curr Drug Saf; 2010 Jul; 5(3):190-3. PubMed ID: 20210733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the VKORC1 genotype on warfarin dose requirements in Japanese pediatric patients.
    Kato Y; Ichida F; Saito K; Watanabe K; Hirono K; Miyawaki T; Yoshimura N; Horiuchi I; Taguchi M; Hashimoto Y
    Drug Metab Pharmacokinet; 2011 Jun; 26(3):295-9. PubMed ID: 21273734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.
    Yuan HY; Chen JJ; Lee MT; Wung JC; Chen YF; Charng MJ; Lu MJ; Hung CR; Wei CY; Chen CH; Wu JY; Chen YT
    Hum Mol Genet; 2005 Jul; 14(13):1745-51. PubMed ID: 15888487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.
    Wu AH; Wang P; Smith A; Haller C; Drake K; Linder M; Valdes R
    Pharmacogenomics; 2008 Feb; 9(2):169-78. PubMed ID: 18370846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients.
    Obayashi K; Nakamura K; Kawana J; Ogata H; Hanada K; Kurabayashi M; Hasegawa A; Yamamoto K; Horiuchi R
    Clin Pharmacol Ther; 2006 Aug; 80(2):169-78. PubMed ID: 16890578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients.
    Mushiroda T; Ohnishi Y; Saito S; Takahashi A; Kikuchi Y; Saito S; Shimomura H; Wanibuchi Y; Suzuki T; Kamatani N; Nakamura Y
    J Hum Genet; 2006; 51(3):249-253. PubMed ID: 16432637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of VKORC1 (C1173T) and CYP2C9 genetic polymorphisms in Egyptians and their influence on warfarin maintenance dose: proposal for a new dosing regimen.
    El Din MS; Amin DG; Ragab SB; Ashour EE; Mohamed MH; Mohamed AM
    Int J Lab Hematol; 2012 Oct; 34(5):517-24. PubMed ID: 22533669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of VKORC1 and CYP2C9 polymorphisms in the interethnic variability of warfarin dose in Malaysian populations.
    Gan GG; Phipps ME; Lee MM; Lu LS; Subramaniam RY; Bee PC; Chang SH
    Ann Hematol; 2011 Jun; 90(6):635-41. PubMed ID: 21110192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethnic differences in CYP2C9*2 (Arg144Cys) and CYP2C9*3 (Ile359Leu) genotypes in Japanese and Israeli populations.
    Nakai K; Habano W; Nakai K; Fukushima N; Suwabe A; Moriya S; Osano K; Gurwitz D
    Life Sci; 2005 Nov; 78(1):107-11. PubMed ID: 16111713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vitamin K epoxide reductase complex 1 gene polymorphism and warfarin dose requirement in Chinese patients].
    Jiang NX; Song J; Xu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):652-4. PubMed ID: 17961434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of VKORC1-1639G > A genetic polymorphism upon warfarin dose requirement in different ethnic populations.
    Jin B; Hong Y; Zhu J; Li Y; Shi HM
    Curr Med Res Opin; 2014 Aug; 30(8):1505-11. PubMed ID: 24708259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.
    Kimura R; Miyashita K; Kokubo Y; Akaiwa Y; Otsubo R; Nagatsuka K; Otsuki T; Okayama A; Minematsu K; Naritomi H; Honda S; Tomoike H; Miyata T
    Thromb Res; 2007; 120(2):181-6. PubMed ID: 17049586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement.
    Kim HS; Lee SS; Oh M; Jang YJ; Kim EY; Han IY; Cho KH; Shin JG
    Pharmacogenet Genomics; 2009 Feb; 19(2):103-12. PubMed ID: 19077919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.
    Carlquist JF; Horne BD; Muhlestein JB; Lappé DL; Whiting BM; Kolek MJ; Clarke JL; James BC; Anderson JL
    J Thromb Thrombolysis; 2006 Dec; 22(3):191-7. PubMed ID: 17111199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1173C>T polymorphism in VKORC1 modulates the required warfarin dose.
    Kosaki K; Yamaghishi C; Sato R; Semejima H; Fuijita H; Tamura K; Maeyama K; Yamagishi H; Sugaya A; Dodo H; Tanigawara Y; Takahashi T
    Pediatr Cardiol; 2006; 27(6):685-8. PubMed ID: 17031720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic distribution of warfarin and its clinical significance in Korean patients during initial anticoagulation therapy.
    Kwon A; Jo SH; Im HJ; Jo YA; Park JY; Kang HJ; Kim HS; Cho HC; Lee YK
    J Thromb Thrombolysis; 2011 Nov; 32(4):467-73. PubMed ID: 21713378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.